Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.550
-0.060 (-3.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $74.80 million as of December 20, 2024. Its market cap has decreased by -11.43% in one year.
Market Cap
74.80M
Enterprise Value
-54.84M
1-Year Change
-11.43%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $74.80M, a decrease of -86.48%. That is a compound annual growth rate of -41.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 74.80M | -21.32% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 79.56M |
| 23andMe Holding Co. | 79.06M |
| Adlai Nortye | 78.97M |
| ALX Oncology Holdings | 78.06M |
| InspireMD | 77.73M |
| I-Mab | 77.69M |
| PMV Pharmaceuticals | 77.62M |
| Quince Therapeutics | 77.44M |